ReviewESMO open2022

Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma.

D V T Catenacci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.